Ornidazole is a synthetic nitroimidazole compound used as an active pharmaceutical ingredient. It is produced commercially through an acid-catalyzed reaction between 2-methyl-5-nitroimidazole and epichlorohydrin.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 16773-42-5
Desmopressin diacetate
pharmaceutical raw material
Flibanserin
pharmaceutical raw material
(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
pharmaceutical raw material
Rimonabant
pharmaceutical raw material
Levornidazole
pharmaceutical raw material
1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
IPWKIXLWTCNBKN-UHFFFAOYSA-N
CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-]